UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies.

Lythgoe MP., Sullivan R., Blagden S.

DOI

10.1016/S1470-2045(23)00218-8

Type

Journal

Lancet oncol

Publication Date

09/2023

Volume

24

Pages

963 - 966

Keywords

Humans, United Kingdom, Medical Oncology, Drug Approval, Antineoplastic Agents

Permalink Original publication